2+ has been implicated in the pathogenesis of neuronal disorders, such as Alzheimer's disease. Various mechanisms produce abnormalities in intracellular Ca 2+ homeostasis systems. L-type Ca 2+ channels have been known to be closely involved in the mechanisms underlying the neurodegenerative properties of amyloid-β (Aβ) peptides. However, most studies of L-type Ca 2+ channels in Aβ-related mechanisms have been limited to Ca V 1.2, and surprisingly little is known about the involvement of Ca V 1.3 in Aβ-induced neuronal toxicity. In the present study, we examined the expression patterns of Ca V 1.3 after Aβ 25-35 exposure for 24 h and compared them with the expression patterns of Ca V 1.2. The expression levels of Ca V 1.3 were not significantly changed by Aβ 25-35 at both the mRNA levels and the total protein level in cultured hippocampal neurons. However, surface protein levels of Ca V 1.3 were significantly increased by Aβ 25-35 , but not by Aβ 35-25 . We next found that acute treatment with Aβ 25-35 increased Ca V 1.3 channel activities in HEK293 cells using whole-cell patch-clamp recordings. Furthermore, using GTP pulldown and co-immunoprecipitation assays in HEK293 cell lysates, we found that amyloid precursor protein interacts with β 3 subunits of Ca 2+ channels instead of Ca V 1.2 or Ca V 1.3 α 1 subunits. These results show that Aβ 25-35 chronically or acutely upregulates Ca V 1.3 in the rat hippocampal and human kidney cells (HEK293). This suggests that Ca V 1.3 has a potential role along with Ca V 1.2 in the pathogenesis of Alzheimer's disease.
INTRODUCTION

Overload of intracellular Ca
2+ has been implicated in the pathogenesis of neuronal disorders, such as Alzheimer's disease, epilepsy, ischemia, and seizures (Choi, 1995; Kim and Rhim, 2004; Pierrot et al., 2004) . In the central nervous system (CNS), mechanisms that produce abnormalities in intracellular Ca 2+ homeostasis systems include aberrant Ca 2+ influx through plasma membrane channels including the N-methyl-D-aspartic acid receptors and voltage-gated calcium channels (CanoAbad et al., 2001; Kim et al., 2008; Luo et al., 2005; Sattler and Tymianskin, 2000) . Among several types of voltage-gated Ca 2+ channels, L-type Ca 2+ channels have been known to be closely involved in the mechanisms underlying the neurodegenerative properties of amyloid-β (Aβ) peptides. After a report that amyloid β-protein fragment [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] ) causes reversible and reproducible increases in intracellular Ca 2+ concentration ([Ca 2+ ] i ) along with bursts of excitatory potentials in cultured hippocampal neurons (Brorson et al., 1995) , the role of L-type Ca 2+ channels in Aβ 25-35 neurotoxicity was further examined using selective blockers of Ca 2+ channels (Ueda et al., 1997) . When L-type Ca 2+ channels were blocked by application of nimodipine, a selective blocker for L-type Ca 2+ channels, Aβ 25-35 neurotoxicity was attenuated. In contrast, application of ω-conotoxin GVIA or ω-agatoxin IVA, which act as blockers for Nor P/Q-type Ca 2+ channels, had no effects on cultured rat cortical and hippocampal neurons. Later, L-type Ca 2+ channel blockers were also found to have neuroprotective effects against Aβ-induced neuronal apoptosis in cultured rat cortical neurons (Yagami et al., 2004) and from amyloid precursor protein (APP)-induced neurotoxicity in neuroblastoma cells (Anekonda et al., 2011) . Furthermore, increased intraneuronal resting [Ca 2+ ] i was reported in neurons obtained from a mouse model of Alzheimer's disease. The increased [Ca 2+ ] i was partially reduced by application of a selective L-type Ca 2+ channel blocker, nifedipine, or a non-L-type channel blocker, SKF-96365 (Lopez et al., 2008) .
Using whole-cell patch-clamp recordings, the involvement of L-type Ca 2+ channels in Aβ-induced neuronal apoptosis has been directly demonstrated. Green and Peers (2001) have shown that Aβ selectively upregulates native L-type Ca 2+ currents in PC12 cells, while other voltage-gated Ca 2+ channels are unaffected. In various neuronal cells, bath application of Aβ produced a reversible increase in Ca 2+ channel currents. This effect was blocked by treatment with nifedipine (Rovira et al., 2002; Ueda et al., 1997) . In the CNS, there are 2 main types of L-type Ca 2+ channels; Ca V 1.2 and Ca V 1.3. While the involvement of Ca V 1.2 in Aβ-induced neuronal apoptosis has been previously studied, the relevance of Ca V 1.3 to Aβ-induced neuronal apoptosis is poorly understood. Therefore, we examined the expression patterns of Ca V 1.3 before and after Aβ 25-35 exposure in cultured hippocampal neurons and the regulation of Ca V 1.3 channel currents by acute Aβ 25-35 exposure using wholecell patch-clamp recordings in Ca V 1.3 expressed HEK293 cells.
MATERIALS AND METHODS
Materials
Aβ 25-35 , Aβ 35-25 , anti-β-actin, and anti-Flag antibodies were purchased from Sigma Aldrich (USA). Nifedipine was pur-chased from Tocris (USA). Anti-Ca V 1.2 and anti-Ca V 1.3 antibodies were obtained from Alomone Labs (Israel). Anti-GST and antimyc antibodies were purchased from Novagen (USA) and Cell Signaling Technology (USA), respectively. All other chemicals were purchased from Sigma Aldrich.
RNA isolation and RT-PCR analysis
The total RNA from each sample was extracted using the easy-BLUETM kit (iNtRON Biotech, Korea) according to the manufacturer's instructions. Total RNA samples were treated with DNase I before cDNA synthesis and quantified using ultraviolet spectrophotometry. Single-strand cDNAs were then synthesized in a reverse transcription (RT) reaction in the presence of 2 μg of total RNA, 0.1 nmol of specific antisense primer, and first-strand cDNA synthesis mix (iNtRON Biotech) containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl 2 , 10 mM dithiothreitol, 0.25 mM of each dNTP, and 100 units of Moloney murine leukemia virus reverse transcriptase. The sequences of the primers and the predicted sizes of PCR products were previously reported by Kim et al. (2007) . Using these primers, amplification of cDNA fragments was performed by PCR with 25-28 cycles with 1 μl of each RT product as template DNA in 60 mM Tris-HCl (pH 9.1) buffer containing 18 mM (NH 4 ) 2 SO 4 , 16 mM MgCl 2 , 0.25 mM of each dNTP, 0.1 nmol of each primer, and Ex-Taq DNA polymerase (Takara, Japan). Each sample (5 μl) of final PCR product was separated using a 1.5-2.5% agarose gel and visualized using UV fluorescence after staining with ethidium bromide for 15 min. The β-actin, as a template control, was included in each run.
Cell culture and transfection HEK293 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 μg/ml) in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. For electrophysiological recordings of Ca V 1.3 channel currents, HEK293 cells were transiently transfected with Ca V 1.3 α 1 and β 3 subunits using Lipofectamine 2000 (Invitrogen, USA). Cultured hippocampal neurons were prepared using a technique modified from Kim et al. (2007) . Briefly, the hippocampi were isolated from 18-day-old fetal Sprague-Dawley rats and incubated with 0.25% trypsin in Leibovitz L-15 medium (Invitrogen). Cells were then mechanically dissociated and plated on poly-L-lysinecoated culture dishes. Cultures were maintained in Neurobasal/B27 medium (Invitrogen) containing 0.5 mM L-glutamine, 25 μM 2-mercaptoethanol, 100 units/ml penicillin, and 100 μg/ml streptomycin under a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Experiments were carried out on neurons after 5-10 days in vitro.
Western blot analysis of Ca V 1.2 or Ca V 1.3 protein expression For the detection of Ca V 1.2 or Ca V 1.3, cultured hippocampal neurons were treated with Aβ 25-35 or Aβ 35-25 for 24 h, and the prepared protein samples were separated on 6% SDS-PAGE. The proteins then transferred to a polvinylidene difluoride membrane (Millipore, USA). The membrane was first blocked with PBS containing 5% skim milk and 0.1% Tween 20 for 1 h. After 3 washes, the membranes were incubated with antiCa V 1.2 (1:150 dilution) or anti-Ca V 1.3 (1:150 dilution) antibodies for 20 h at room temperature in PBS containing 1% skim milk and 0.1% Tween 20. For a positive control, anti-β-actin antibodies (1:2500 dilution) were incubated for 1 h. After 3 washes, the membranes were incubated with peroxidase-conjugated secondary antibodies in PBS containing 3% skim milk and 0.1% Tween 20 for 2 h at room temperature. The signal resulting from the immunoreactivity was detected using a western blot detection reagent (Elipis Biotech, Korea). For the detection of each channel's surface protein, biotinylation of cell surface proteins was performed using the Pinpoint Cell Surface Protein Isolation kit (Pierce) according to the manufacturer's instructions as previously described by Yun et al. (2007) .
Electrophysiological recording
Ca V 1.3 channel currents were measured in HEK293 cells transfected with Ca V 1.3 α 1 subunits using Ba 2+ as a charge carrier with standard whole-cell patch-clamp techniques. Borosilicate glass electrodes were filled with the internal solution containing (in mM): 135 CsCl, 10 EGTA, 4 MgCl 2 , 10 HEPES, and 4 Mg-ATP (pH 7.4). The external solution contained (in mM): 135 CholineCl, 5 BaCl 2 , 1 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4). Cells were held at a holding potential of -70 mV, and currents were elicited with step depolarizations from -60 mV to +30 mV (10 mV increments) for 200 ms. All of the data were obtained and analyzed using an EPC-10 amplifier and Pulse/ Pulsefit software program (HEKA, Germany).
GST pulldown assays GST pulldown assays were performed with purified GST and various GST-tagged proteins using the ProFound Pull-Down GST Protein:Protein Interaction Kit (Pierce, USA). The immobilized GST or various GST-tagged proteins were incubated with cell lysates prepared from HEK293 cells. Glutathionebound proteins were eluted by boiling at 95°C in SDS sample buffer for 10 min, and detected by immunoblotting with antiCa V 1.2, anti-Ca V 1.3, anti-GST, or anti-Flag antibodies.
Co-immunoprecipitation assay
Co-immunoprecipitation (co-IP) assays were performed using the ProFound Mammalian Co-Immunoprecipitation Kit (Pierce). Briefly, lysates from HEK293 cells were precleared, immunoprecipitated with 10 μg of a specific antibody and 50 μl of AminoLink ® Plus Coupling Gel at 4°C for 6 h or overnight, and washed 5 times. Immune complexes were eluted using IgG Elution Buffer (Pierce) or by boiling at 95°C in SDS-sample buffer for 10 min, and detected by immunoblotting with antiCa V 1.2, anti-Ca V 1.3, anti-myc, or anti-Flag antibodies.
RESULTS AND DISCUSSION
To elucidate the involvement of Ca V 1.3 L-type Ca 2+ channels in the mechanisms underlying the neurodegenerative properties of Aβ peptides, we examined the expression profiles of Ca V 1.2 and Ca V 1.3 before and after treatment with Aβ 25-35 in cultured rat hippocampal neurons. Treatment with 25 nM Aβ 25-35 for 24 h significantly increased both total and surface Ca V 1.2 protein levels as well as Ca V 1.2 mRNA levels while there was no significant change observed upon treatment with the inverted sequence of Aβ 25-35 , amyloid β-protein fragment 35-25 (Aβ 35-25 ) (Figs. 1A-1C) . However, the expression levels of Ca V 1.3 were not significantly changed by either Aβ 25-35 or Aβ 35-25 both at the mRNA and total protein levels. Interestingly, Ca V 1.3 proteins were significantly increased only at the surface level by Aβ 25-35 , but not byAβ (Fig. 1C) . For Ca V 1.2, we also observed the increased surface level by Aβ 25-35 , but not byAβ . Figure 1D Aβ 35-25 on relative mRNA or protein levels of Ca V 1.2 and Ca V 1.3. These results suggest that Aβ 25-35 -induced expression profiles of Ca V 1.3 mRNA and total proteins are different from the profiles of Ca V 1.2, and both channels are similarly upregulated at the surface level only in an Aβ 25-35 specific manner in cultured hippocampal neurons. We next examined whether acute treatment with Aβ 25-35 modulates Ca V 1.3 channel activities using whole-cell patchclamp recordings. When Ca V 1.3 α 1 and β 3 subunits were transiently transfected in HEK293 cells, GFP was also co-transfected to identify positively transfected cells. Using Ba 2+ as a charge carrier, Ca V 1.3 channel currents were measured in transfected cells only as previously described in Park et al. (2010) . When Aβ 25-35 was applied to the perfusate, Ba 2+ currents were rapidly increased. This was maximally observed at a test pulse of -10 mV ( Fig. 2A) . In Fig. 2B, upper 
that Ba
2+ currents were predominantly recorded via an activation of Ca V 1.3 channels. Aβ 25-35 significantly increased the peak currents of Ca V 1.3 (8.93 ± 0.65 pA/pF in control; 16.40 ± 1.97 pA/pF in the presence of Aβ 25-35 , n = 10), but did not cause any shift in the current-voltage curve in Fig. 2C . Addition of Aβ 35-25 at the same concentration as Aβ 25-35 (25 nM) did not produce any effect on peak currents of Ca V 1.3 (n = 5). This is summarized in Fig. 2D . These results provide the first experimental evidence that acute treatment with Aβ 25-35 increases Ca V 1.3 L-type Ca 2+ currents in HEK293 cells.
For the possible mechanisms of Aβ-induced upregulation of Ca V 1.3, we attempted to determine whether a direction association occurs between α 1 subunits of L-type Ca 2+ channels and full length amyloid precursor protein (APP695). We performed GST pulldown assays using GST-tagged APP695 and a GSTtagged fragment of APP695, which contains the amino acid sequence from 306 to 695 (APP390, Fig. 3A ). After GST, GST-APP695, and GST-APP390 were expressed in Escherichia coli, they were immobilized by glutathione-agarose 4B. Then, the lysates from the HEK293 cells overexpressing α 1 subunits of Ca V 1.2 or Ca V 1.3 were incubated with the glutathione-agarose 4B bound to GST-APP695 or GST-APP390. As shown in Fig.  3B and 3C, GST-APP695 was shown not to interact with either Ca V 1.2 or Ca V 1.3. Using GST-APP390, we also found that there is no interaction of Ca V 1.2 or Ca V 1.3 with APP390. There- fore, using an in vivo co-IP assay, we further examined a direct interaction between L-type Ca 2+ channels and APP695 in HEK293 cells overexpressing myc-tagged APP695 and one of the L-type Ca 2+ channels (Fig. 3D) . For the Ca V 1.2 channels, cell lysates were prepared, immunoprecipitated with anti-Ca V 1.2 antibodies, and subsequently immunoblotted with anti-myc antibodies. As shown in Fig. 3E , no positive signal was detected. When co-IP was performed in reverse with anti-myc antibodies followed by immunoblotting with anti-Ca V 1.2, the result was the same. For the examination of a direct interaction between Ca V 1.3 with APP695, cell lysates were prepared, immunoprecipitated with anti-Ca V 1.3 antibodies, and subsequenttly immunoblotted with anti-myc antibodies. In addition, co-IP was performed in reverse with anti-myc antibodies followed by immunoblotting with anti-Ca V 1.3. However, we found that there is no association between Ca V 1.3 and APP695 in HEK293 cells (Fig. 3F) . Then, what is the mechanism of Aβ-induced upregulation of Ca V 1.3 evidenced by the data shown in Figs. 1 and 2 ? In native brain tissues, α 1 subunits of Ca 2+ channels interact with other auxiliary subunits, e.g., α 2 δ, β, and γ subunits, to provide complete activity and functional regulation. In a heterologous expression system such as the HEK293 cells used in this study, other auxiliary subunits of Ca 2+ channels are required when α 1 subunits are expressed for their full activation. In the present study, we used HEK293 cells transfected with Ca V 1.3 α 1 and β 3 subunits. Therefore, we examined the possible involvement of β 3 subunits as modulators of Aβ-induced upregulation of L-type Ca 2+ channels. We performed GST pulldown assays to observe the specific interaction between APP and β 3 subunits. As shown in Figs. 4A and 4B, GST-APP695 or GST-APP390 interacts with Flag-tagged β 3 subunits in HEK293 cell lysates expressing β 3 subunits while GST alone (a negative control) was found to not interact with the β 3 subunits. Subsequently, using an in vivo co-IP assay, we confirmed the association of APP and β 3 subunits in HEK293 cells expressing myc-tagged APP695 and Flag-tagged β 3 subunits. Cell lysates prepared from HEK293 cells were immunoprecipitated with anti-myc antibodies, and subsequently immunoblotted with anti-Flag antibodies. In Fig. 4C , APP binds to endogenous β 3 subunits in HEK293 cells whereas no signal was detected in an IgG control. These results strongly suggest that a specific interaction between APP and β 3 subunits occurs in mammalian cells.
Herein, we present 3 principal findings regarding possible roles of Ca V 1.3 in Aβ-induced neuronal toxicity. First, we found that the expression levels of Ca V 1.3 are moderated only at the surface protein level by chronic treatment with Aβ. This pattern is the different from the Ca V 1.2 pattern. In the current study, the 24 h treatment with Aβ 25-35 significantly increased both total and surface Ca V 1.2 protein levels as well as Ca V 1.2 mRNA levels while there was no significant change when Aβ 35-25 , the reverse amino acid sequence peptide of Aβ 25-35 , was used. In addition, Aβ-mediated upregulation of Ca V 1.2 was previously reported with respect to mRNA and total protein levels (Chiou, 2006) as well as surface protein levels (Scragg et al., 2004) . Our results with respect to Ca V 1.3 mRNA and total protein levels were consistent with the previous findings using human SK-N-SH neuroblastoma cells. When the expression patterns of 4 α 1 subunits of P/Q (Ca V 2.1)-, N (Ca V 2.2)-, and L (Ca V 1.2 and Ca V 1.3)-type Ca 2+ channels before and after Aβ exposure were investigated in SK-N-SH cells, no significant changes were observed with respect to Ca V 1.3 mRNA and total protein levels (Chiou, 2006) . Because the surface protein levels were not examined by Chiou (2006) , we first reported that the 24 h treatment with Aβ selectively upregulates the Ca V 1.3 surface expression in cultured hippocampal neurons.
Secondly, we found that acute treatment with Aβ 25-35 increased Ca V 1.3 channel activities using whole-cell patch-clamp recordings in HEK293 cells. Direct evidence for the involvement of L-type Ca 2+ channels in Aβ-induced neuronal toxicity was obtained from the electrophysiological studies of endogenous L-type Ca 2+ channels in neurons or cell lines expressing Ca V 1.2 in heterologous systems (Green and Peers, 2001; Rovira et al., 2002; Ueda et al., 1997) . Because there were no reports examining the acute effects of Aβ on Ca V 1.3 channel activities using electrophysiological tools, we attempted to examine them in HEK293 cells transiently expressing Ca V 1.3 α 1 and β 3 subunits. On the basis of our data, it appears that Ca V 1.3 could be directly modulated by Aβ, and the degree of upregulation is very similar to that of Ca V 1.2 determined in HEK293 cells (Scragg et al., 2004) . Although the augmentation of currents by Aβ 25-35 is apparent in the present study, it is also interesting to examine effects of the predominant 2 toxic forms of A β peptides, Aβ 1-40 and Aβ 1-42 , on Ca V 1.3 channel activities.
What is a possible mechanism of Aβ-induced upregulation of Ca V 1.2 and Ca V 1.3 both chronically and acutely? As the third and final piece of evidence on the possible roles of Ca V 1.3 in Aβ-induced neuronal toxicity, we found that β 3 auxiliary subunits of Ca 2+ channels may play an important role in Aβ-induced upregulation of Ca V 1.2 and Ca V 1.3. On the basis of experiments using GST pulldown and co-IP assays, we clearly determined that neither Ca V 1.2 nor Ca V 1.3 binds to APP in both the GST pulldown and the co-IP experiments. However, we demonstrated that β 3 subunits of Ca 2+ channels interact with APP695 or APP390. This suggests a possible role of β 3 subunits of Ca 2+ channels in Aβ-induced neuronal toxicity. It is possible that APP, which contains the Aβ fragment, increases surface expression of Ca V 1.3 or functional activities of Ca V 1.3 via an interaction with β 3 subunits. However, for the detailed mechanism of Aβ-induced upregulation of Ca V 1.3, it is necessary to demonstrate whether Aβ interacts with β 3 subunits in the brain using binding assays or to elucidate binding sequences of APP using mapping studies.
A number of recent studies have shown that Aβ can disrupt neuronal Ca 2+ homeostasis by inducing influx of extracellular Ca 2+ into the neuronal cytoplasm (Anekonda et al., 2011; Small et al., 2009; Supnet and Bezprozvanny, 2010) . Among the functions of voltage-gated Ca 2+ channels regulating neuronal excitability, synaptic plasticity, and neurotoxicity, functions of the neuronal L-type Ca 2+ channels are distinguished from the functions of the N-and P/Q-type Ca 2+ channels. N-and P/Qtype Ca 2+ channels clearly play central roles in controlling Ca 2+ entry into, and thus neurotransmitter release from, neuronal synaptic terminals in the CNS (Catterall, 1999; Dunlap et al., 1995) . On the other hand, neuronal L-type Ca 2+ channels are known to be involved in translating synaptic activity into alterations in gene expression and neuronal cell death (Cano-Abad et al., 2001; Finkbeiner and Greenberg, 1997; Fuchs, 1996; Luo et al., 2005) . This is related to the Aβ specific increases in the quantity and activity of L-type Ca 2+ channels caused by Aβ. Among the possible mechanisms underlying Aβ-induced Ca 2+ dysregulation, Aβ can increase ion permeability in lipid membranes or activate endogenous ion channels on the cell surface (Small et al., 2009) . In the present study, we showed that Aβ does not change the amount of mRNA of Ca V 1.3 but dramatically alters the quantity of surface proteins of Ca V 1.3. This provides further support for the results showing that Aβ activates endogenous ion channels on the cell surface. Therefore, the Aβ-induced increase in surface proteins of Ca V 1.3 could provide more surface-expressed L-type Ca 2+ channels, which deteriorate and cause neuronal cell death via Ca 2+ overload. In summary, using expression profiling and electrophysiological studies as well as in vivo binding assays, we showed the first evidence of Aβ-mediated upregulation of Ca V 1.3 surface proteins and Ca V 1.3 channel activities and further originally demonstrated direct binding between APP and β 3 subunits of Ca 2+ channels. These results may help elucidate pivotal roles of L-type Ca 2+ channels in intracellular Ca 2+ disturbance in Alzheimer's disease. It is likely that elucidation of the mechanism by which Aβ cause Ca 2+ dysregulation via L-type Ca 2+ channels will help identify new drug targets for the treatment of Alzheimer's disease.
